{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:29:10Z","timestamp":1787758150694,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Breast cancer is among the most common malignancies in women around the world. There is evidence of high prevalence of serum\/blood Vitamin D deficiency in Iranian women. Considering the multitude of factors that may be involved in the prognosis and lifespan of breast cancer patients, this study investigated the level of Vitamin D in Iranian patients with nonmetastatic breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study was carried out on 214 women diagnosed with breast cancer, who were referred to the radio-oncology department. Serum Vitamin D level of the patients was measured. Prognostic factors were determined based on demographic and pathological characteristics. The results were analyzed using descriptive statistics tests, Chi-square, one-way analysis of variance, Kaplan\u2013Meier, and Cox regression model in SPSS v22. For all cases, the significance level was considered to be\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The total mean of 25-hydroxyvitamin D serum level was 25.15 \u00b1 17.68 ng\/ml. There was no significant relationship between levels of Vitamin D with disease stage, tumor size, tumor grade, estrogen receptor, progesterone receptor, and Human epidermal growth factor receptor 2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). The mean survival time was 5 years and 45 days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>No relationship was found between serum Vitamin D levels and the factors affecting the prognosis of nonmetastatic breast cancer. The Cox analysis showed that the survival time was not influenced by Vitamin D as a prognosis factor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_951_21","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:22:58Z","timestamp":1659079378000},"page":"56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Association between serum Vitamin D levels and prognostic factors in nonmetastatic breast cancer patients"],"prefix":"10.4103","volume":"27","author":[{"given":"Mohammad Karim","family":"Shahrzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Gharehgozlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fadaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Hajian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-56-20240830","first-page":"39","article-title":"year survival of breast cancer in Shohada-e-Tajrish and Jorjani hospitals","volume":"9","author":"Akbari","year":"2006","journal-title":"Hakim"},{"key":"R2-56-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/jrms.JRMS_353_18","article-title":"Impaired fasting glucose in breast cancer survivors of a general hospital at Mexico City: A case series study","volume":"24","author":"Ortiz-Mendoza","year":"2019","journal-title":"J Res Med Sci"},{"key":"R3-56-20240830","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/jrms.JRMS_708_19","article-title":"Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression","volume":"25","author":"Krishnamoorthy","year":"2020","journal-title":"J Res Med Sci"},{"key":"R4-56-20240830","doi-asserted-by":"crossref","first-page":"112038","DOI":"10.1016\/j.biopha.2021.112038","article-title":"Marine peptides in breast cancer: Therapeutic and mechanistic understanding","volume":"142","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R5-56-20240830","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","article-title":"Incidence and mortality and epidemiology of breast cancer in the world","volume":"17","author":"Ghoncheh","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"R6-56-20240830","doi-asserted-by":"crossref","first-page":"112600","DOI":"10.1016\/j.biopha.2021.112600","article-title":"Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target","volume":"146","author":"Jafarzadeh","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R7-56-20240830","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/tbj.14021","article-title":"The role of Epstein-Barr virus-expressed genes in breast cancer development","volume":"26","author":"Mostafaei","year":"2020","journal-title":"Breast J"},{"key":"R8-56-20240830","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1566524020666200712182137","article-title":"Vitamin D and Non-coding RNAs: New insights into the regulation of breast cancer","volume":"21","author":"Shahrzad","year":"2021","journal-title":"Curr Mol Med"},{"key":"R9-56-20240830","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1002\/jcp.26379","article-title":"Breast cancer diagnosis: Imaging techniques and biochemical markers","volume":"233","author":"Jafari","year":"2018","journal-title":"J Cell Physiol"},{"key":"R10-56-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yclnex.2016.12.001","article-title":"Vitamin D and breast cancer: Indian perspective","volume":"12","author":"Haq","year":"2017","journal-title":"Clin Nutr Exp"},{"key":"R11-56-20240830","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.7314\/APJCP.2016.17.3.1393","article-title":"Breast cancer in Iranian woman: Incidence by age group, morphology and trends","volume":"17","author":"Rafiemanesh","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"R12-56-20240830","doi-asserted-by":"crossref","first-page":"2481021","DOI":"10.1155\/2017\/2481021","article-title":"Breast cancer status in Iran: Statistical analysis of 3010 cases between 1998 and 2014","volume":"2017","author":"Akbari","year":"2017","journal-title":"Int J Breast Cancer"},{"key":"R14-56-20240830","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The global burden of women's cancers: A grand challenge in global health","volume":"389","author":"Ginsburg","year":"2017","journal-title":"Lancet"},{"key":"R15-56-20240830","first-page":"19","article-title":"The quality of life of breast cancer patients receiving palliative and supportive care","volume":"3","author":"Mirzaei","year":"2017","journal-title":"Iran J Rehabil Res"},{"key":"R16-56-20240830","first-page":"26","article-title":"The effectiveness of reality therapy on the hope of breast cancer patients","volume":"6","author":"Ebadi","year":"2013","journal-title":"ijbd"},{"key":"R17-56-20240830","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2014.00213","article-title":"The impact of vitamin D in breast cancer: Genomics, pathways, metabolism","volume":"5","author":"Narvaez","year":"2014","journal-title":"Front Physiol"},{"key":"R18-56-20240830","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/jcp.25738","article-title":"Anti-atherosclerotic effects of vitamins D and E in suppression of atherogenesis","volume":"232","author":"Rashidi","year":"2017","journal-title":"J Cell Physiol"},{"key":"R19-56-20240830","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/2230-8210.95684","article-title":"Vitamin D deficiency in newly diagnosed breast cancer patients","volume":"16","author":"Imtiaz","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"R20-56-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jsbmb.2005.06.016","article-title":"NIH deltanoids meeting on Vitamin D and cancer. Conclusion and strategic options","volume":"97","author":"Bouillon","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R21-56-20240830","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1634\/theoncologist.2011-0098","article-title":"Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: A systematic review","volume":"16","author":"Buttigliero","year":"2011","journal-title":"Oncologist"},{"key":"R22-56-20240830","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/cancers9100144","article-title":"Association of vitamin D3 level with breast cancer risk and prognosis in African-American and hispanic women","volume":"9","author":"Wu","year":"2017","journal-title":"Cancers (Basel"},{"key":"R23-56-20240830","first-page":"1178223417749816","article-title":"Vitamin D and breast cancer: Latest evidence and future steps","volume":"11","author":"Atoum","year":"2017","journal-title":"Breast Cancer (Auckl"},{"key":"R24-56-20240830","doi-asserted-by":"crossref","first-page":"645","DOI":"10.12669\/pjms.333.11753","article-title":"Association between Vitamin D deficiency and Breast Cancer","volume":"33","author":"Shaukat","year":"2017","journal-title":"Pak J Med Sci"},{"key":"R25-56-20240830","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10552-012-0140-6","article-title":"Serum 25-hydroxyvitamin D and breast cancer in the military: A case-control study utilizing pre-diagnostic serum","volume":"24","author":"Mohr","year":"2013","journal-title":"Cancer Causes Control"},{"key":"R26-56-20240830","first-page":"1381","article-title":"Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer","volume":"12","author":"Kermani","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"R27-56-20240830","first-page":"125","article-title":"High prevalence of vitamin D deficiency among Iranian population: A systematic review and meta-analysis","volume":"43","author":"Tabrizi","year":"2018","journal-title":"Iran J Med Sci"},{"key":"R28-56-20240830","doi-asserted-by":"crossref","first-page":"e15461","DOI":"10.5812\/ircmj.15461","article-title":"Risk factors and prevalence of vitamin d deficiency among Iranian women attending two university hospitals","volume":"16","author":"Alipour","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"R29-56-20240830","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice. Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"R30-56-20240830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/erc.0.0090045","article-title":"Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer","volume":"9","author":"Colston","year":"2002","journal-title":"Endocr Relat Cancer"},{"key":"R31-56-20240830","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1245\/s10434-010-1465-6","article-title":"Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer","volume":"18","author":"Kim","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R32-56-20240830","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4048\/jbc.2018.21.2.134","article-title":"Association between changes in serum 25-hydroxyvitamin D levels and survival in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"21","author":"Kim","year":"2018","journal-title":"J Breast Cancer"},{"key":"R33-56-20240830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-14-29","article-title":"Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: A nested case-control study in the multiethnic cohort study","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"key":"R34-56-20240830","doi-asserted-by":"crossref","first-page":"ix26","DOI":"10.1016\/S0923-7534(21)00250-7","article-title":"90P prognostic value of vitamin-D level in non-metastatic breast cancer patients in Saudi Arabia","volume":"27","author":"Elsamany","year":"2016","journal-title":"Ann Oncol"},{"key":"R35-56-20240830","first-page":"571","article-title":"Prognostic significance of serum vitamin D levels in egyptian females with breast cancer","volume":"19","author":"Ismail","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"R36-56-20240830","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jsbmb.2017.10.009","article-title":"Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women","volume":"174","author":"de Sousa Almeida-Filho","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R37-56-20240830","first-page":"30","article-title":"A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer","volume":"10","author":"Janbabai","year":"2016","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"R38-56-20240830","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1245\/s10434-012-2297-3","article-title":"The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels","volume":"19","author":"Peppone","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R39-56-20240830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/bcr3178","article-title":"Vitamin D and the mammary gland: A review on its role in normal development and breast cancer","volume":"14","author":"Lopes","year":"2012","journal-title":"Breast Cancer Res"},{"key":"R40-56-20240830","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_951_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:02Z","timestamp":1787756882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_951_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_951_21","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}